Foetal Liver Suspensions in the Treatment of Marrow Aplasia
1964

Foetal Liver Suspensions in the Treatment of Marrow Aplasia

Sample size: 15 publication Evidence: low

Author Information

Author(s): J. B. Bridges, J. M. Bridges, G. J. A. Edelstyn, A. R. Lyons

Primary Institution: Queens' University of Belfast

Hypothesis

Can foetal liver suspensions effectively treat patients with marrow failure?

Conclusion

Foetal liver suspensions showed little therapeutic value in treating marrow failure, with only a few patients experiencing temporary recovery.

Supporting Evidence

  • Three out of ten patients with toxic marrow failure recovered normal marrow function.
  • None of the five patients with non-toxic marrow failure showed improvement after the infusion.
  • One patient experienced a temporary recovery, but there was no evidence of long-term benefit from the infused cells.

Takeaway

Doctors tried using foetal liver cells to help sick patients, but it mostly didn't work.

Methodology

The study involved infusing foetal liver suspensions into fifteen patients with severe marrow failure.

Limitations

The study had a small sample size and did not show significant clinical benefits for most patients.

Participant Demographics

Patients included ten with toxic marrow failure and five with non-toxic marrow failure.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication